The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
UBPY: a growth‐regulated human ubiquitin isopeptidase
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
UBPy protein levels decrease when cells undergo growth arrest by contact inhibition.
“Protein levels of UBPy decrease, when cells undergo growth arrest by contact inhibition, suggesting a possible role in the control of mammalian-cell proliferation (40).”
From Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo (2007) · cites this paper as [40]
UBPy is a growth-regulated ubiquitin isopeptidase that accumulates upon growth stimulation.
“USP8 (UBPy/HUMORF8) was first described as a growthregulated ubiquitin isopeptidase that accumulates upon growth stimulation.”
From Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo (2007) · cites this paper as [40]
USP8 is indispensable to cellular proliferation and survival.
“An essential growth-regulated enzyme, USP8, is indispensable to cellular proliferation and survival (23,24).”
From Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex (2010) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746
Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts
Pagano, M., Theodoras, A. M., Tam, S. W., & Draetta, G. F. (1994) · Genes & Development · doi:10.1101/gad.8.14.1627 · Cited by 294
Self-citation
Flagged first, then by citations
Research works printed but not linked: 41
- Baker RT, Tobias JW and Varshavsky A (1992) Ubiquitin‐specific proteases of Saccharomyces cerevisiae. Cloning of UBP2 and UBP3, and functional analysis of the UBP gene family. J Biol Chem, 267, 23364–23375. · DOI
- Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem, 72, 248. · DOI · Paper page
- Ciechanover A (1994) The ubiquitin–proteasome proteolytic pathway. Cell, 79, 13–21. · DOI
- Draetta G and Pagano M (1996) Cell cycle control and cancer. In Wong,W.W. (ed.), Annual Reports in Medical Chemistry. Vol. 32. Academic Press, pp. 241–248.
- Ellison MJ and Hochstrasser M (1991) Epitope‐tagged ubiquitin. A new probe for analyzing ubiquitin function. J Biol Chem, 266, 21150–21157. · DOI
- Everett RD, Meredith M, Orr A, Cross A, Kathoria M and Parkinson J (1997) A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J, 16, 1519–1530. · DOI
- Falquet L, Paquet N, Frutiger S, Hughes GJ, Hoang‐Van K and Jaton JC (1995a) cDNA cloning of a human 100 kDa de‐ubiquitinating enzyme: the 100kDa human de‐ubiquitinase belongs to the ubiquitin C‐terminal hydrolase family 2 (UCH2). FEBS Lett, 376, 233–237. · DOI
- Falquet L, Paquet N, Frutiger S, Hughes GJ, Hoang‐Van K and Jaton JC (1995b) A human de‐ubiquitinating enzyme with both isopeptidase and peptidase activities in vitro. FEBS Lett, 359, 73–77. · DOI
- Fischer‐Vize JA, Rubin GM and Lehmann R (1992) The fat facets gene is required for Drosophila eye and embryo development. Development, 116, 985–1000. · DOI
- Goldberg AL (1995) Functions of the proteasome: the lysis at the end of the tunnel. Science, 268, 522–523. · DOI
- Gray DA, Inazawa J, Gupta K, Wong A, Ueda R and Takahashi T (1995) Elevated expression of Unph, a proto‐oncogene at 3p21.3, in human lung tumors. Oncogene, 10, 2179–2183.
- Guadagno T, Ohtsubo M, Roberts J and Assoian R (1993) A link between cyclin A expression and adhesion‐dependent cell cycle progression. Science, 262, 1572–1575. · DOI
- Gupta K, Chevrette M and Gray DA (1994) The Unp proto‐oncogene encodes a nuclear protein. Oncogene, 9, 1729–1731.
- Gupta K, Copeland N, Gilbert D, Jenkins N and Gray D (1993) Unp, a mouse gene related to the tre oncogene. Oncogene, 8, 2307–2310.
- Hateboer G, Kerkhoven RM, Shvarts A, Bernards R and Beijersbergen RL (1996) Degradation of E2F by the ubiquitin–proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev, 10, 2960–2970. · DOI
- Henchoz S, De Rubertis F, Pauli D and Spierer P (1996) The dose of a putative ubiquitin‐specific protease affects position‐effect variegation in Drosophila melanogaster. Mol Cell Biol, 16, 5717–5725. · DOI
- Hochstrasser M (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol, 7, 215–223. · DOI
- Huang Y, Baker RT and Fischer‐Vize JA (1995) Control of cell fate by a deubiquitinating enzyme encoded by the fat facets gene. Science, 270, 1828–1831. · DOI
- Huebner K, Cannizzaro LA, Nakamura T, Hillova J, Mariage‐Samson R, Hecht F, Hill M and Croce CM (1988) A rearranged transforming gene, tre, is made up of human sequences derived from chromosome regions 5q, 17q and 18q. Oncogene, 3, 449–455.
- Jaster R, Zhu Y, Pless M, Bhattacharya S, Mathey‐Prevot B and D'Andrea AD (1997) JAK2 is required for induction of the murine DUB‐1 gene. Mol Cell Biol, 17, 3364–3372. · DOI
- Jonnalagadda S, Butt TR, Marsh J, Sternberg EJ, Mirabelli CK, Ecker DJ and Crooke ST (1987) Expression and accurate processing of yeast penta‐ubiquitin in Escherichia coli. J Biol Chem, 262, 17750–17756. · DOI
- Kalderon D (1996) Protein degradation: de‐ubiquitinate to decide your fate. Curr Biol, 6, 662–665. · DOI
- Kumar S, Kao WH and Howley PM (1997) Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J Biol Chem, 272, 13548–13554. · DOI
- Moazed D and Johnson D (1996) A deubiquitinating enzyme interacts with SIR4 and regulates silencing in S.cerevisiae. Cell, 86, 667–677. · DOI
- Mueller H, Moroni MC, Vigo E, Otzen Petersen B, Bartek J and Helin K (1997) Induction of S‐phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol, 17, 5508–5520. · DOI
- Nakamura T, Hillova J, Mariage‐Samson R and Hill M (1988) Molecular cloning of a novel oncogene generated by DNA recombination during transfection. Oncogene Res, 2, 357–370.
- Nakamura T, Hillova J, Mariage‐Samson R, Onno M, Huebner K, Cannizzaro LA, Boghosian‐Sell L, Croce CM and Hill M (1992) A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene, 7, 733–741.
- Nomura N et al. (1994) Prediction of the coding sequences of unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041–KIAA0080) deduced by analysis of cDNA clones from human cell line KG‐1. DNA Res, 1, 223–229. · DOI · Paper page
- Pagano M (1997) Cell cycle regulation by the ubiquitin pathway. FASEB J, 11, 1067–1075. · DOI
- Pagano M, Beer‐Romero P, Glass S, Tam S, Theodoras A, Rolfe M and Draetta G (1995a) Targeting Ubiquitin‐mediated Degradation for Proliferation Inhibitors. In Mihich,E. and Housman,D. (eds), Cancer Genes. Plenum, New York, pp. 241–254.
- Pagano M, Tam SW, Theodoras AM, Romero‐Beer P, Del Sal G, Chau V, Yew R, Draetta G and Rolfe M (1995b) Role of the ubiquitin–proteasome pathway in regulating aboundance of the cyclin‐dependent kinase inhibitor p27. Science, 269, 682–685. · DOI
- Papa FR and Hochstrasser M (1993) The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre‐2 oncogene. Nature, 366, 313–319. · DOI
- Rolfe M, Chiu MI and Pagano M (1997) The ubiquitin‐mediated proteolytic pathway as a therapeutic area. J Mol Med, 75, 5–17. · DOI
- Sherr C and Roberts J (1995) Inhibitors of mammalian G1 cyclin‐dependent kinases. Genes Dev, 9, 1149–1163. · DOI
- Swanson DA, Freund CL, Ploder L, McInnes RR and Valle D (1996) A ubiquitin C‐terminal hydrolase gene on the proximal short arm of the X chromosome: implications for X‐linked retinal disorders. Hum Mol Genet, 5, 533–538. · DOI
- Treier M, Staszewski L and Bohmann D (1994) Ubiquitin‐dependent c‐Jun degradation in vivo is mediated by the domain. Cell, 78, 787–798. · DOI
- van den Heuvel S and Harlow E (1993) Distinct roles for cyclin‐dependent kinases in cell cycle control. Science, 262, 2050–2054. · DOI
- Wilkinson KD (1997) Regulation of ubiquitin‐dependent processes by deubiquitinating enzymes. FASEB J, 11, 1245–1256. · DOI
- Wilkinson KD, Tashayev VL, O'Connor LB, Larsen CN, Kasperek E and Pickart CM (1995) Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry, 34, 14535–14546. · DOI
- Zhu Y, Lambert K, Corless C, Copeland NG, Gilbert DJ, Jenkins NA and D'Andrea AD (1997) DUB‐2 is a member of a novel family of cytokine‐inducible deubiquitinating enzymes. J Biol Chem, 272, 51–57. · DOI
- Zhu Y, Pless M, Inhorn R, Mathey‐Prevot B and D'Andrea AD (1996) The murine DUB‐1 gene is specifically induced by the beta subunit of interleukin‐3 receptor. Mol Cell Biol, 16, 4808–4817. · DOI
Cited by
Sorted by citations
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Chemistry-Based Functional Proteomics Reveals Novel Members of the Deubiquitinating Enzyme Family
Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L., & Kessler, B. M. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00248-x · Cited by 588
Niendorf, S., Oksche, A., Kisser, A., Löhler, J., Prinz, M., Schorle, H., Feller, S., Lewitzky, M., Horak, I., & Knobeloch, K.-P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01566-06 · Cited by 207
Ovaa, H., Kessler, B. M., Rolén, U., Galardy, P. J., Ploegh, H. L., & Masucci, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308411100 · Cited by 190
Berlin, I., Schwartz, H., & Nash, P. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016287 · Cited by 121
Metadata
- Authors
- Naviglio, S., Matteucci, C., Matoskova, B., Nagase, T., Nomura, N., Di Fiore, P. P., & Draetta, G. F.
- Venue
- The EMBO Journal
- Published
- 1998-06-15
- Volume
- 17
- Issue
- 12
- Pages
- 3241-3250
- ISSN
- 0261-4189
- 1460-2075
- Cited by
- 174
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review